Medicaid Expansion Tied to Increase in Diagnoses of HIV
MONDAY, Feb. 8, 2021 -- Medicaid expansions are associated with increases in the percentage of people living with HIV who are aware of their status and with greater use of preexposure prophylaxis, according to a study published online Jan. 24 in the American Journal of Preventive Medicine.
Bita Fayaz Farkhad, Ph.D., from the University of Illinois at Urbana-Champaign, and colleagues estimated the effects of the Medicaid expansions using data on HIV diagnoses per 100,000 population, awareness of HIV status, and preexposure prophylaxis use. The analysis compared data before and after the expansions, as well as differences between treatment counties (all counties in states that expanded Medicaid) and control counties (all counties in states that did not expand Medicaid).
The researchers found that Medicaid expansion was associated with an increase in HIV diagnoses of 0.508 per 100,000 population, or 13.9 percent. Medicaid expansion also was associated with improvements in the knowledge of HIV status and preexposure prophylaxis use. However, there were no associations seen between expansions and incident HIV, substance use, or sexually transmitted infection rates, with the exception of gonorrhea, which decreased after expansions. Changes in new HIV diagnoses, awareness of HIV status, and preexposure prophylaxis use were not simply due to a higher incidence or an increase in infection risk.
"Expanding public health insurance may be an avenue for curbing the HIV epidemic," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
THURSDAY, Feb. 25, 2021 -- For women aged younger than 65 years, the mortality gap between cancer and heart disease is narrowing, according to a study published online Feb. 8 in...
THURSDAY, Feb. 25, 2021 -- Negative changes in brain volumes and cognitive scores persist over time in children with early-onset type 1 diabetes, according to a study published...
THURSDAY, Feb. 25, 2021 -- There is underrepresentation of racial/ethnic minorities and older patients among U.S.-based vaccine clinical trials, while female adults are...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.